ArticleImmunity, inflammation and disease2026
Repeated Episodes of GPP Induced by Respiratory Infections Are Mediated by Loss-of-Function IFIH1.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repeated Episodes of GPP Induced by Respiratory Infections Are Mediated by Loss-of-Function IFIH1.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGeneralized pustular psoriasis (GPP) is a severe and recurrent autoinflammatory disease that can be induced by a variety of factors. At present, its etiology and pathogenesis have not yet been fully elucidated. Upper respiratory tract infections are the main predisposing factor in children with GPP, and the MDA5 protein encoded by the IFIH1, functions as a key receptor for sensing upper respiratory tract viruses and may contribute to the induction of antiviral and immunological responses.
methodsWe performed whole-exome sequencing in 80 pediatric GPP patients and conducted rare variant association analyses against healthy controls. Structural and expression analyses of mutant MDA5 were performed to evaluate mechanistic consequences. Identified IFIH1 variants were functionally characterized using IFN-β luciferase reporter assays, circular dichroism spectroscopy, and protein stability assays.
resultsWe identified eight IFIH1 rare variants in 10 pediatric GPP patients, accounting for 12.5% of the total cohort. Association analyses revealed a significantly higher prevalence of rare variants of IFIH1 in GPP patients as compared to healthy controls. IFIH1 variation was found to cause structural changes or decreased expression of its encoded protein MDA5, the intrinsic stability of the mutant was lower than that of the wild-type IFIH1. Notably, functional assays demonstrated that these IFIH1 variants (6/8) substantially impaired the production of interferon beta (IFN-β).
conclusionThis study suggests that loss-of-function variants in IFIH1 may be associated with the pathogenesis of recurrent episodes of GPP triggered by URTI. These findings offer a theoretical basis for the development of targeted etiological and pathogenetic preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.